Bupropion-varenicline interactions and nicotine self-administration behavior in rats

Pharmacology Biochemistry and Behavior

Volumn 130, Issue , 2015, Pages 84-89

  Hall, Brandon J ^a   Slade, Susan ^a   Wells, Corinne ^a   Rose, Jed E ^a   Levin, Edward D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bupropion; Interactions; Nicotine; Self administration; Varenicline

Indexed keywords

AMFEBUTAMONE; NICOTINE; SODIUM CHLORIDE; VARENICLINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SELF ADMINISTRATION; FEMALE; FOLLOW UP; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOKING CESSATION; TOBACCO DEPENDENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; DOSE RESPONSE;

ANIMALIA; NICOTIANA TABACUM; RATTUS;

ANIMALS; BUPROPION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; NICOTINE; RATS; SELF ADMINISTRATION; VARENICLINE;

EID: 84921833533     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2015.01.009     Document Type: Article

References (31)

1. T. Bordia, M. Hrachova, M. Chin, J.M. McIntosh, and M. Quik Varenicline is a potent partial agonist at alpha6beta2∗ nicotinic acetylcholine receptors in rat and monkey striatum J Pharmacol Exp Ther 342 2012 327 334
2. CDC National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Department of Health and Human Services Smoking and tobacco use - fact sheet: health effects of cigarette smoking 2014 [Date Accessed: 12/01/14. http://www.cdc.gov/tobacco/data-statistics/fact-sheets/fast-facts/index.htm#toll ]
3. J.F. Cryan, A.W. Bruijnzeel, K.L. Skjei, and A. Markou Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat Psychopharmacology 168 2003 347 358
4. J.O. Ebbert, I.T. Croghan, A. Sood, D.R. Schroeder, J.T. Hays, and R.D. Hurt Varenicline and bupropion sustained-release combination therapy for smoking cessation Nicotine Tob Res 11 2009 234 239
5. J.O. Ebbert, D.K. Hatsukami, I.T. Croghan, D.R. Schroeder, S.S. Allen, and J.T. Hays Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial JAMA 311 2014 155 163
6. FDA FDA 101: smoking cessation products Date Accessed: 12/01/2014 http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm198176.htm 2012
7. O. George, A. Lloyd, F.I. Carroll, M.I. Damaj, and G.F. Koob Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration Psychopharmacology 213 2011 715 722
8. B.J. Hall, C. Wells, C. Allenby, M.Y. Lin, I. Hao, and L. Marshall Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats Pharmacol Biochem Behav 120 2014 103 108
9. M. Igari, J.C. Alexander, Y. Ji, X. Qi, R.L. Papke, and A.W. Bruijnzeel Varenicline and cytisine diminish the dysphoric-like state associated with spontaneous nicotine withdrawal in rats Neuropsychopharmacology 39 2014 455 465
10. D.E. Jorenby, J.T. Hays, N.A. Rigotti, S. Azoulay, E.J. Watsky, and K.E. Williams Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial JAMA 296 2006 56 63
11. J.E. Johnson, S. Slade, C. Wells, A. Petro, H. Sexton, and A.H. Rezvani Assessing the effects of chronic sazetidine - a delivery on nicotine self-administration in both male and female rats Psychopharmacology 222 2012 269 276
12. D.E. Jorenby, S.J. Leischow, M.A. Nides, S.I. Rennard, J.A. Johnston, and A.R. Hughes A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation N Engl J Med 340 1999 685 691
13. C.F. Koegelenberg, F. Noor, E.D. Bateman, R.N. van Zyl-Smit, A. Bruning, and J.A. O'Brien Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial JAMA 312 2014 155 161
14. B. Le Foll, M. Chakraborty-Chatterjee, S. Lev-Ran, C. Barnes, A. Pushparaj, and I. Gamaleddin Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used Int J Neuropsychopharmacol 15 2012 1265 1274
15. E.D. Levin, C. Wells, J. Johnson, A.H. Rezvani, F.P. Bymaster, and J.E. Rose Amitifadine (EB-1010), a triple dopamine, norepinepherine and serotonin reuptake inhibitor, reduces nicotine self-administration in female rats Aug 30-Sept 2, 2012 Society for Research on Nicotine and Tobacco - Europe, Annual Meeting Helsinki, Finland
16. X. Liu, A.R. Caggiula, M.I. Palmatier, E.C. Donny, and A.F. Sved Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose Psychopharmacology 196 2008 365 375
17. R.J. Lukas, A.Z. Muresan, M.I. Damaj, B.E. Blough, X. Huang, and H.A. Navarro Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation J Med Chem 53 2010 4731 4748
18. D.H. Malin, J.R. Lake, T.D. Smith, H.N. Khambati, R.L. Meyers-Paal, and A.L. Montellano Bupropion attenuates nicotine abstinence syndrome in the rat Psychopharmacology 184 2006 494 503
19. K.B. Mihalak, F.I. Carroll, and C.W. Luetje Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors Mol Pharmacol 70 2006 801 805
20. E.C. O'Connor, D. Parker, H. Rollema, and A.N. Mead The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats Psychopharmacology 208 2010 365 376
21. N.E. Paterson, D.J. Balfour, and A. Markou Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell Eur J Neurosci 25 2007 3099 3108
22. N.E. Paterson, D.J. Balfour, and A. Markou Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats Nicotine Tob Res 10 2008 995 1008
23. A.S. Rauhut, L.P. Dwoskin, and M.T. Bardo Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration Nicotine Tob Res 7 2005 901 907
24. A.S. Rauhut, N. Neugebauer, L.P. Dwoskin, and M.T. Bardo Effect of bupropion on nicotine self-administration in rats Psychopharmacology 169 2003 1 9
25. V.I. Reus, R.S. Obach, J.W. Coe, H. Faessel, H. Rollema, and E. Watsky Varenicline: new treatment with efficacy in smoking cessation Drugs Today 43 2007 65 75
26. H. Rollema, L.K. Chambers, J.W. Coe, J. Glowa, R.S. Hurst, and L.A. Lebel Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid Neuropharmacology 52 2007 985 994
27. J.E. Rose, and F.M. Behm Adapting smoking cessation treatment according to initial response to precessation nicotine patch Am J Psychiatry 170 2013 860 867
28. J.E. Rose, and F.M. Behm Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm Am J Psychiatry 171 2014 1199 1205
29. D.J. Stairs, N.M. Neugebauer, X. Wei, C. Boustany, M. Hojahmat, and L.A. Cassis Effects of nornicotine enantiomers on intravenous S(-)-nicotine self-administration and cardiovascular function in rats Psychopharmacology 190 2007 145 155
30. S. Veldheer, J. Yingst, G. Foulds, S. Hrabovsky, A. Berg, and C. Sciamanna Once bitten, twice shy: concern about gaining weight after smoking cessation and its association with seeking treatment Int J Clin Pract 68 2014 388 395
31. J.A. Wouda, D. Riga, W. De Vries, M. Stegeman, Y. van Mourik, and D. Schetters Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control Psychopharmacology 216 2011 267 277